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Abstract
Background: Multiplex detection of low-level mutant alleles in the presence of wild-type DNA would be useful for several
fields of medicine including cancer, pre-natal diagnosis and infectious diseases. COLD-PCR is a recently developed method
that enriches low-level mutations during PCR cycling, thus enhancing downstream detection without the need for special
reagents or equipment. The approach relies on the differential denaturation of DNA strands which contain Tm-lowering
mutations or mismatches, versus ‘homo-duplex’ wild-type DNA. Enabling multiplex-COLD-PCR that can enrich mutations in
several amplicons simultaneously is desirable but technically difficult to accomplish. Here we describe the proof of principle
of an emulsion-PCR based approach that demonstrates the feasibility of multiplexed-COLD-PCR within a single tube, using
commercially available mutated cell lines. This method works best with short amplicons; therefore, it could potentially be
used on highly fragmented samples obtained from biological material or FFPE specimens.
Methods: Following a multiplex pre-amplification of TP53 exons from genomic DNA, emulsions which incorporate the
multiplex product, PCR reagents and primers specific for a given TP53 exon are prepared. Emulsions with different TP53
targets are then combined in a single tube and a fast-COLD-PCR program that gradually ramps up the denaturation
temperature over several PCR cycles is applied (temperature-tolerant, TT-fast-eCOLD-PCR). The range of denaturation
temperatures applied encompasses the critical denaturation temperature (Tc) corresponding to all the amplicons included
in the reaction, resulting to a gradual enrichment of mutations within all amplicons encompassed by emulsion.
Results: Validation for TT-fast-eCOLD-PCR is provided for TP53 exons 6–9. Using dilutions of mutated cell-line into wild-type
DNA, we demonstrate simultaneous mutation enrichment between 7 to 15-fold in all amplicons examined.
Conclusions: TT-fast-eCOLD-PCR expands the versatility of COLD-PCR and enables high-throughput enrichment of low-level
mutant alleles over multiple sequences in a single tube.
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Introduction
Detection of low-level mutant alleles in the presence of wild-type
DNA is important in several fields of medicine, including cancer,
pre-natal diagnosis and infectious diseases [1]. A number of
approaches have been described that enrich the abundance of low-
level mutant allelic burden present in biological specimens, so that
mutations can subsequently be detected [1]. These include
electrophoretic or enzymatic approaches, which require multiple
reagents or specialized equipment. Co-amplification of major and
minor DNA alleles at Lower Denaturation temperature (COLD-
PCR) represents a PCR-based technique that enriches mutation-
containing sequences by adjusting the denaturation temperature to
within ,0.3uC of a critical temperature (Tc). This enables
preferential amplification of mutated sequences during the PCR
cycling program irrespective where the mutation lies on the
amplicon [2]. A main advantage of this procedure is its simplicity,
since it does not require new instrumentation, special reagents or
additional processing. This makes COLD-PCR accessible to
different laboratory settings [3] that employ a variety of
downstream mutation detection assays including high resolution
melting, HRM [4–8], Sanger sequencing [9–12], mass-spectrom-
etry [2], real time PCR [13,14] and RFLP analysis [15].
A COLD-PCR drawback is that it is not easily scalable for
enriching mutations in diverse amplicons simultaneously, since
generally, a different Tc applies to each amplicon. The re-
quirement for determining Tc with a precision of ,0.3uC means
that Tc is subject to variations due to different brand thermo-
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[16]. For this reason, we recently developed temperature-tolerant-
COLD-PCR (TT-COLD-PCR), a modified form of COLD-PCR
that applies to all COLD-PCR formats described, [2,17]. TT-
COLD-PCR relaxes the stringency on Tc and allows sequences of
different Tc to be amplified using a single thermo-cycling program
[16]. In TT-COLD-PCR, amplification starts at a lower Tc and
increases gradually over several PCR cycles, spanning an overall
2–3uC temperature window. This enables enrichment of muta-
tions in all amplicons whose Tc lies within the temperature
window [16]. Yet individual DNA targets still need to be amplified
in separate tubes using TT-COLD-PCR and adaptation to
multiplex formats is difficult in view of primer-primer interactions.
Multiple primer interactions can be even more problematic for
COLD-PCR compared to conventional PCR, in view of the low
denaturation temperatures applied that may enhance primer-
dimer formation and non-specific amplification products.
In this work we demonstrate that the problem of multiplexing
COLD-PCR can be overcome by employing temperature-tolerant
amplification in emulsion. We describe a COLD-PCR protocol
that allows simultaneous enrichment of mutations in multiple
DNA targets of different Tm in a single tube by applying
a temperature-tolerant cycling protocol in emulsion. PCR
amplification inside water-in-oil emulsion enables compartmen-
talization that eliminates multiple primer interactions when co-
amplifying complex DNA templates [18–20]. We demonstrate the
application of temperature-tolerant fast-COLD-PCR in emulsion
(TT-fast-eCOLD-PCR, Figure 1) by enriching mutations in four
exons of the TP53 gene, in a single tube.
Materials and Methods
Reference human genomic DNA obtained from Promega, Inc.
(catalog number G1471, Madison, WI, USA) was used as wild
type control and for preparing dilutions with mutant cell lines.
Genomic DNA from cell lines with TP53 mutations in exons 6–9
Figure 1. Temperature-tolerant-fast-COLD-PCR in emulsion: Overview of the steps involved. Multiplex pre-amplification from genomic
DNA; emulsification with gene-specific primers; mixing into a single tube; and temperature-tolerant emulsion-based fast-COLD-PCR.
doi:10.1371/journal.pone.0051362.g001
Table 1. Cell lines used in the present study.
Gene and amplicon Cell line Mutation (nt) Mutation (aa)
TP53 Exon 6 SNU-182 c.644G.T p.S215I
Exon 7 HCC2157 c.742C.T p.R248W
Exon 8 SW480 c.818G.A p.R273H
Exon 9 SW480 c.925C.T p.P309S
doi:10.1371/journal.pone.0051362.t001
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genomic DNA mixture containing 5% mutant DNA abundance,
resulting from a combination of DNA from mutated cell lines into
human male genomic DNA, was tested. To obtain a simplified
genomic template for subsequent TT-fast-COLD-ePCR reactions,
exons 2–11 of TP53 gene were pre-amplified in a single multiplex-
PCR reaction from genomic DNA as reported by Fredriksson [21]
with minor modifications [22]. Briefly, multiplex reactions were
performed in 15 ml final reaction volumes containing 16
Phusion
TM high-fidelity (HF) buffer, 0.2 mmol/L (each) dNTPs,
0.1 mmol/L (each) primers, and 0.6 U Phusion
TM high fidelity
DNA polymerase (New England Biolabs Inc., Ipswich, MA),
reported to have an error rate of 4.2610
27. Primers were
synthesized by Integrated DNA Technologies (IDT Inc., Coral-
ville, IA, USA) and are summarized in Table 2.
For emulsion-PCR/COLD-PCR, the aqueous phase of the
reaction (50 ml volume) was prepared individually for each target
amplicon with 0.2 mmol/L amplicon-specific primers (F and R),
16 Phusion
TM Buffer, 0.2 mmol/L (each) dNTPs, 2 U of
Phusion
TM DNA polymerase, 16 LCGreen (Idaho Technology
Inc., Salt Lake City, Utah, USA) and 2 ml of DNA template up to
50 ml with water. The oil phase of the reaction was prepared as
described [23–25]; 4.5% Span 80 (product no. S6760, Sigma
Aldrich, USA), 0.4% Tween 80 (product no. P1754, Sigma
Aldrich, USA), 0.05% Triton X-100 (part no. T1001, Affymetrix,
USA) were mixed with 100% mineral oil (product no. M5904,
Sigma Aldrich) to 50 ml. Then, 300 ml of the oil phase was mixed
with 50 ml of the aqueous phase in separate tubes for each of the
target amplicons and vortexed for 5 min at high speed. 100 ml
aliquots were used during the amplification reaction to ensure
proper heat distribution.
In preliminary experiments, the optimal amount of target DNA
molecules per micelle was determined for each target amplicon
and appropriate dilutions from the pre-amplification product were
used as template for TT-fast-eCOLD-PCR. TT-fast-eCOLD-
PCR was performed using the guidelines described, and with
minor modifications, per Table 3. To retrieve amplified DNA
following TT-fast-eCOLD-PCR, corresponding samples were
transferred to 1.5 ml tubes and centrifuged for 5 min at
13,000 g [23,24] to remove the upper oil phase. Then, samples
were mixed with 1 ml of butanol (catalog. no. B7906, Sigma
Aldrich, USA) by vortexing and further purified using the Qiagen
purification kit according to manufacturer’s instructions [25]. To
analyze the amplified DNA, following emulsion removal, re-
covered DNA was further amplified by conventional PCR using
nested primers specific for each amplicon in the presence of 1X
LCGreen intercalating dye. The products were analyzed using
high resolution melting (HRM) with a Light Scanner HR96 system
(Idaho Technologies, Inc.) and Sanger-sequenced at Eton Bio-
science, Inc. (Cambridge, MA, USA). Sanger chromatograms
were analyzed with BioEdit v7.1.3 (Ibis Biosciences, Abbott
Laboratories, USA) to determine the approximate mutational load
from the peak height as previously described [17]. All experiments
were repeated multiple independent times.
Table 2. Primer sequences used in this study.
Gene and amplicons PCR Round Primer sequences (5’ to 3’)
1 Amplicon size (bp)
TP53 Exon 2–11
2 Pre-amplification (multiplex reaction) Exon 2–3 ATGCTGGATCCCCACTTTTC (F)3 5 0
GACCAGGTCCTCAGCCC (R)
Exon 4 GACAAGGGTTGGGCTGG (F)4 8 6
CCAAAGGGTGAAGAGGAATC (R)
Exon 5–6 TCTTTGCTGCCGTCTTCC (F)5 1 7
AGGGCCACTGACAACCAC (R)
Exon 7 TGCTTGCCACAGGTCTCC (F)2 3 5
GTCAGAGGCAAGCAGAGGC (R)
Exon 8–9 GGACAGGTAGGACCTGATTTCC (F)4 4 1
AAACAGTCAAGAAGAAAACGGC (R)
Exon 10 AACTTGAACCATCTTTTAACTCAGG (F)2 4 3
GGAATCCTATGGCTTTCCAAC (R)
Exon 11 AGGGGCACAGACCCTCTC (F)2 2 2
AGACCCAAAACCCAAAATGG (R)
TP53 Exon 6–9 TT-fast-COLD-ePCR Exon 6
3 TCACTGATTGCTCTTAGGTCT (F) 144
GTTGCAAACCAGACCTC (R)
Exon 7 TCTTGGGCCTGTGTTAT (F) 122
AGTGTGATGATGGTGAG (R)
Exon 8
3,4 TTGCTTCTCTTTTCCTAT (F) 115
GCGGAGATTCTCTTC (R)
Exon 9
3 AGGGTGCAGTTATGCCTCAG (F) 114
TCTCCATCCAGTGGTTTCTTC (R)
1Oligonucleotides (F) forward or (R) reverse.
2Oligonucleotide sequences described before [21,22].
3Oligonucleotides from Castellanos et al. [16].
4Primer sequences described previously [2,17].
doi:10.1371/journal.pone.0051362.t002
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step, a control experiment was performed by performing a sub-
sequent, nested real time PCR using LC-Green dye from the
emulsion-PCR and comparing the real-time PCR threshold
difference with and without the emulsion-PCR step. Furthermore,
to ensure that amplification takes place solely within the emulsion
Table 3. PCR thermocycling conditions utilized in the present work.
PCR type Step Conditions TauC
Multiplex-PCR
1 (pre-amplification) Initial denaturation 98uC for 30 s
Thermocycling: 35 cycles 98uC for 10 s Exon 2–11 TP53, 55uC
55uC for 20 s
72uC for 10 s
Extension 72uC for 15 s
Stage 1 cycling: 5 times 95uC for 10 s
Ta for 20 s
72uC for 10 s
Stage 2 cycling: 8 times 85.2uC for 10 s
Ta for 20 s
72uC for 10 s
Stage 3 cycling: 8 times 85.5uC for 10 s
Ta for 20 s
72uC for 10 s
Stage 4 cycling: 8 times 85.8uC for 10 s
Ta for 20 s
72uC for 10 s
Stage 5 cycling: 8 times 86.1uC for 10 s
Ta for 20 s
72uC for 10 s
TT-fast-COLD- PCR Stage 6 cycling: 8 times 86.4uC for 10 s Exon 6–9 TP53, 58uC
Ta for 20 s
72uC for 10 s
Stage 7 cycling: 8 times 86.7uC for 10 s
Ta for 20 s
72uC for 10 s
Stage 8 cycling: 8 times 87uC for 10 s
Ta for 20 s
72uC for 10 s
Stage 9 cycling: 8 times 87.3uC for 10 s
Ta for 20 s
72uC for 10 s
Stage 10 cycling: 8 times 87.6uC for 10 s
Ta for 20 s
72uC for 10 s
Stage 11 cycling: 8 times 87.9uC for 10 s
Ta for 20 s
72uC for 10 s
Stage 12 cycling: 8 times 88.2uC for 10 s
Ta for 20 s
72uC for 10 s
Stage 13 cycling: 8 times 88.5uC for 10 s
Ta for 20 s
72uC for 10 s
1Conditions from a previous study [22].
doi:10.1371/journal.pone.0051362.t003
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Biolabs, MA) was added to the reactions to eliminate the
extracellular portion of the PCR primers. Experiments to validate
the efficient degradation of PCR primers in the aqueous phase of
the sample by ExoI were performed, with and without forming the
emulsion (5 min vigorous vortexing versus gently mixing the oil
and aqueous phase, respectively).
Results
Emulsion-PCR Validation
The present procedures yield formation of emulsions with
diameters of 3–10 mm( Figure S1). We verified efficient
amplification in emulsion (ePCR) by monitoring the product yield
(Ct value) in a subsequent, nested real-time PCR reaction that
utilizes diluted ePCR product as a template. In Figure S2, panel
A shows 10 cycles PCR threshold difference in the nested PCR
between emulsified-amplified DNA and versus an identically
treated sample where the ePCR step was omitted. In panel B, we
observe that, when ExoI is added, in the absence of emulsion there
is no PCR product formed, presumably due to the anticipated
ssDNA (primer) hydrolysis by ExoI. In contrast, when the emulsion
is formed in the same samples by 5 min vigorous vortexing,
subsequent addition of ExoI does not inhibit PCR, consistent with
the expectation that the hydrophilic ExoI does not penetrate the
emulsion. These data are consistent with amplification taking
place within the emulsion efficiently and not in the extracellular
space when ExoI is present. ExoI was added to the reactions
described below to exclude amplification taking place outside
emulsions.
TT-fast-eCOLD-PCR for Individual Amplicons
Figure S3 demonstrates that mutation enrichments of ,7–15
fold are obtained for exons 6–9 when these are amplified as
separate, single-amplicon reactions. This figure depicts TT-fast-
eCOLD-PCR applied in emulsion, using as starting material
genomic DNA containing 5% mutant DNA, and followed by
Sanger sequencing of the final product. In contrast, when
conventional PCR, instead of COLD-PCR, is applied to the
same emulsions, the 5% mutant peaks are not visible in any of the
chromatograms, indicating the efficient enrichment of mutations
using the TT-fast-eCOLD-PCR cycling program.
TT-fast-eCOLD-PCR for TP53 Exons 6–9 in a Single Tube
To perform TT-fast-eCOLD-PCR in a single tube for all targets
(Figure 1), TP53 exons 6–9 were emulsified individually then
Figure 2. Temperature-tolerant COLD-PCR in emulsion, TT-fast-eCOLD-PCR: Enrichment of mutations in multiple DNA sequences in
a single tube. A 5% mutation abundance was evaluated for TP53 gene exons 6–9 by conventional PCR (left panels) and TT-fast-eCOLD-PCR (right
panels). Duplicate experiments are depicted in each case. The enrichment of the mutations in all four exons is estimated from the chromatograms.
doi:10.1371/journal.pone.0051362.g002
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Mastercycler (Eppendorf Inc., Haupage, NY). The TT-fast-
eCOLD-PCR program (Table 3) was designed to simultaneously
amplify exons 6–9 of TP53 gene as described earlier [16], and by
spanning a range of Tc from 85.2uC–88.5uC, with 0.3uC
temperature increments every eight cycles (initial Tc=lowest
melting temperature of the amplicons tested minus 2uC).
Fluorescent difference curve plots relative to wild type DNA
become clearly detectable via HRM analysis in those amplicons
generated by TT-fast-eCOLD-PCR, Figure 2. In contrast, HRM
analysis of the same amplicons amplified by conventional PCR in
emulsion does not show a signal distinct from the wild type profile.
HRM results were further validated via Sanger sequencing,
Figure 2. The data indicate that the mutant abundance displayed
a ,5–10 fold enrichment in all exons simultaneously when
amplified by TT-fast-eCOLD-PCR. These results are comparable
with the mutation enrichment obtained following one-round fast –
COLD-PCR of single amplicons in solution [2]. Therefore, the use
of the emulsion with the multiplex format of TT-fast-COLD-PCR
does not significantly affect the mutation enrichment obtained.
It is noteworthy that when the same TT-fast-COLD-PCR
cycling of the 4 exons is performed in solution, (i.e. in the absence
of emulsion reagents or ExoI), Sanger sequencing depicts mutation
enrichment in 3 out of 4 amplicons (exon 6, 8 and 9), while for
exon 7 no amplification is obtained (Figure S4). The data
indicate that multiple primers in solution lead to primer-primer
interactions that inhibit efficient generation of the amplicon from
exon 7. The compartmentalization provided by the emulsion
reduces multiple primer interactions and overcomes this problem.
Discussion
Since its original description, the development of PCR in
emulsion has been exploited for several applications, such as
quantification of DNA methylation [26], studying in vitro directed
evolution [18,19,27,28] or detection of rare variants at specific
mutation ‘hotspot’ positions [29]. The data presented here provide
proof of principle for one yet application of emulsion-PCR. By
compartmentalizing COLD-PCR reactions and ramping-up the
temperature gradually, multiple targets with different melting
temperature(Tm)andTcareamplifiedandenrichedsimultaneously
while preventing excessive primer and template interactions.
In principle, a high number of amplicons with Tc within the
range covered by the amplification protocol can be co-amplified
using COLD-PCR in emulsion. In practice the rate-limiting step is
the initial pre-amplification stage plus the preparation of emulsions
containing multiplex-PCR targets and discrete primers for each
target. It is envisioned that micro-fluidics can overcome these
limitations. Thus, the number of sequences can be scaled-up by
employing recent developments that merge complex DNA
templates with sequence-specific primers over millions of emul-
sions per experiment [19,30]. These new engineering tools can
facilitate the high-throughput adaptation of the TT-fast-eCOLD-
PCR principle presented in this work. The mutation-enriched
DNA can optionally be combined with high-throughput sequenc-
ing platforms to improve the reliability and lowest limit of
mutation calling [31]. Alternatively, high throughput genotyping
methods (MALDI) can be used as the endpoint detection system
[32].
In the present manuscript we have shown the adaptation of fast-
COLD-PCR format in emulsion. This form of COLD-PCR is
only applicable to mutations that decrease the melting tempera-
ture of the amplicon (G:C.A:T, G:C.T:A, or Tm-reducing
indels). Tm-reducing base substitutions account for the majority of
mutations in cancer [33]. The adaptation of other forms of
COLD-PCR (full- or ice-COLD-PCR) in emulsion, analyzing
clinical samples fresh or in formalin (FFPE), is also desirable and
will be addressed in future work.In summary, we demonstrated
that emulsion-PCR overcomes the limitations of unwanted
multiple-primer interactions during temperature-tolerant COLD-
PCR and enables single-tube amplification and mutation enrich-
ment for multiple target DNA sequences. This development
facilitates multiplexed enrichment and detection of panels of
clinically-relevant mutations to aid prognosis, diagnosis and
management in heterogeneous cancer samples.
Supporting Information
Figure S1 Water in oil emulsion at 1006magnification
with a Zeiss Axioimager Z1 fluorescent microscope
(Carl Zeiss Microscopy, GmbH, Germany) after five
minutes of vortexing.
(TIF)
Figure S2 Validation of emulsion-PCR. Panel A: DNA
amplified by emulsion PCR (ePCR) or where ePCR amplification
was omitted, was evaluated by an additional nested, real-time
qPCR using LCGreen (duplicate reactions). Panel B: Effect of
adding exonuclease I (ExoI) in the sample prior to ePCR, with and
without emulsion formation, as evaluated by nested, qPCR. Left:
aqueous and oil phase without emulsion formation (gently mixed)
with and without ExoI. Right: emulsion (formed by vortexing for
5 min) with and without adding ExoI.
(TIF)
Figure S3 Single-exon amplification in emulsions, in
separate reactions for each TP53 exon, using a 5%
dilution of mutation-containing DNA into wild-type
DNA. A. conventional PCR in emulsion. B. temperature-tolerant
fast COLD-PCR in emulsion.
(TIF)
Figure S4 TT-fast-eCOLD-PCR multiplex (TP53 exons
6–9) amplification in solution (without emulsion forma-
tion), using a 5% dilution of mutation-containing DNA
into wild-type DNA. A. conventional multiplex PCR. B.
temperature-tolerant fast COLD-PCR multiplex in solution.
(TIF)
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